Pulished Date October, 2018
ID: 239
Share on
Share on

The Acute Ischemic Stroke Diagnosis and Treatment Market is predicted to reach $ 2508 million USD with a CAGR of 6.7% according to Market Data Forecast report.

Pulished: October, 2018
ID: 239
Pages: 0

The Acute Ischemic Stroke Treatment and Diagnosis Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Acute Ischemic Stroke Diagnosis and Treatment Market is estimated to be $ 1814 million USD and predicted to rise to $ 2508 million USD with a CAGR of 6.7%. The market is segmented by Diagnostic type (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Cerebral angiography and Nuclear Imaging), Surgery Type (Angioplasty, Carotid Endarterectomy and Endovascular Mechanical Thrombectomy). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Rising prevalence of acute ischemia stroke cases are driving the demand for surgical procedures in acute stroke treatment. Advancements in surgical procedures along with growing geriatric population, increasing demand for minimally invasive procedures and growth in healthcare expenditure are the key factors boosting the growth of Global Acute Ischemic Stroke diagnosis and treatment market. High cost of surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth. Carotid Endarterectomy is the largest segment accounting for a significant share owing to high success rate, short treatment duration and easy availability.

North America is the largest market for Acute Ischemic Stroke Diagnosis and Treatment devices is estimated to continue its strong hold of the market owing to favorable government initiatives, technological innovations and increasing demand for ischemic stroke products. Asia-Pacific is the most promising market for acute ischemic stroke diagnosis owing to increasing prevalence of ischemic stroke cases in this region. Manufacturers are expanding their operations in Asia-Pacific region as these regions hold immense potential for the market growth

Some of the major companies covered in the report are Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-acute-ischemic-stroke-diagnosis-market-265/” and checkout our recent reports in the Diagnostics category at “http://www.marketdataforecast.com/research-reports/healthcare/diagnostics-5/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

LICENCE TYPE

$ 1234 0

Clients
clients
clients
clients
clients
clients
clients

Research Areas